Inventor
MALAGU KARINE FABIENNE
GB27 patents
⚠️ This page may combine multiple inventors who share the name “MALAGU KARINE FABIENNE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
USHER III INITIATIVE INC
7 patentsUS9549910B2Jan 24, 2017
Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome
USHER III INITIATIVE INC3 citations82
US9260381B2Feb 16, 2016
Pyrazolopyridazines and methods for treating retinal degenerative diseases and hearing loss associated with usher syndrome
USHER III INITIATIVE INC4 citations82
US9227976B2Jan 5, 2016
Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome
USHER III INITIATIVE INC6 citations82
US9371332B2Jun 21, 2016
Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with Usher syndrome
USHER III INITIATIVE INC4 citations80
US10307422B2Jun 4, 2019
Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome
USHER III INITIATIVE INC1 citations71
US9783545B2Oct 10, 2017
Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome
USHER III INITIATIVE INC3 citations71
US9925187B2Mar 27, 2018
Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome
USHER III INITIATIVE INC1 citations61
ENYO PHARMA
6 patentsUS11603368B2Mar 14, 2023
Fused thiophene derivatives and their uses
ENYO PHARMA0 citations57
US11492347B2Nov 8, 2022
Fused thiophene derivatives and their uses
ENYO PHARMA1 citations57
US11840527B2Dec 12, 2023
Non-fused thiophene derivatives and their uses
ENYO PHARMA0 citations56
US11767316B2Sep 26, 2023
Non-fused thiophene derivatives and their uses
ENYO PHARMA0 citations56
US11279683B2Mar 22, 2022
Thiophene derivatives as antiviral agents
ENYO PHARMA1 citations54
US11807618B2Nov 7, 2023
Thiophene derivatives as antiviral agents
ENYO PHARMA0 citations53
ABBVIE OVERSEAS SARL
5 patentsUS10988454B2Apr 27, 2021
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
ABBVIE OVERSEAS SARL1 citations70
US10981890B2Apr 20, 2021
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
ABBVIE OVERSEAS SARL0 citations59
US10844041B2Nov 24, 2020
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
ABBVIE OVERSEAS SARL0 citations49
US10844042B2Nov 24, 2020
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
ABBVIE OVERSEAS SARL0 citations49
US10829473B2Nov 10, 2020
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
ABBVIE OVERSEAS SARL0 citations49
KUDOS PHARM LTD
3 patentsUS9102670B2Aug 11, 2015
Pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mTOR inhibitors
KUDOS PHARM LTD5 citations82
US10034884B2Jul 31, 2018
Pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mTOR inhibitors
KUDOS PHARM LTD0 citations50
US9717736B2Aug 1, 2017
Pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mTOR inhibitors
KUDOS PHARM LTD0 citations50
ABBVIE SARL
2 patentsUSHER III INITIATIVE
2 patentsUS9079909B2Jul 14, 2015
Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with Usher Syndrome
USHER III INITIATIVE8 citations81
US8765762B2Jul 1, 2014
Pyrazolopyridazines and methods for treating retinal-degerative diseases and hearing loss associated with usher syndrome
USHER III INITIATIVE11 citations81